Aldeyra Therapeutics, Inc. announced that Stephen Tulipano has joined Aldeyra as its Chief Financial Officer, effective from June 23, 2014. Mr. Tulipano will report directly to Todd C. Brady, M.D., Ph.D., President and CEO of the company. Most recently, Tulipano held positions at Three Tulips Inc., where he provided full-time accounting services and financial management counsel.

Prior to that, he served as Chief Financial Officer of Javelin Pharmaceuticals where he helped lead the company through its acquisition by Hospira in 2010.